News

corona virus 2019-ncov flu outbreak, covid-19 3d banner illustration, microscopic view of floating influenza virus cells

The German National Cohort (NAKO) contributes its scientific expertise to the National Decade of Post-Infectious Diseases initiated by the Federal Ministry of Research, Technology and Space (BMFTR). With two central projects, it makes an important…

Ancient viral remnants embedded in the human genome may be an overlooked driver of Alzheimer’s disease. Dr. Michelle Vincendeau at Helmholtz Munich is investigating how so-called endogenous retroviruses influence disease-relevant mechanisms in human…

Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D) – but which genes and proteins are actually involved in the disease mechanisms? An international team led by Helmholtz Munich has now used globally collected…

Cardiovascular diseases are the leading cause of death worldwide, and lowering blood lipids is a central strategy to reduce risk. Bempedoic acid, a recently approved cholesterol-lowering drug, has now been shown by researchers at Helmholtz Munich to…

Healthy gut bacteria concept with natural probiotics for immune support.

Bacteria in the human gut can directly deliver proteins into human cells, actively shaping immune responses. Led by researchers at Helmholtz Munich, with participation from Ludwig Maximilians University (LMU), Aix Marseille University, Inserm, and…

Intricate network of red capillaries, a detailed view of microscopic blood vessels conveying vitality

Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for…

Fabian Theis bei Eröffnung des Google AI Centers Berlin

On March 5, Google opened its first German AI Center in Berlin. The event was attended by representatives from politics, business, and science, including Federal Research Minister Dorothee Bär, Federal Digital Minister Karsten Wildberger, Berlin's…

Helmholtz Munich has been awarded a prestigious grant of up to 900 000 US Dollar from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support the research into early-stage T1D in adults,…

Dr. Arcangela Iuso from the Institute of Neurogenomics at Helmholtz Munich was awarded the Eva Luise Köhler Research Award. The foundation thus honors a highly innovative research project on RNA base editing for a rare neurodegenerative disease.

News

News

NAKO Participates in the National Decade of Post-Infectious Diseases

Can Ancient Viral Remnants Trigger Alzheimer’s Disease?

Big Data Make Hidden Genetic Drivers of Type 2 Diabetes Visible

Cholesterol-Lowering Drug Found to Target Key Metabolic Switch

More Than Just Gut Cohabitants: How Gut Bacteria Control Immune Responses

New Imaging Technology Detects Early Signs of Heart Disease Through the Skin

People & Grants

Google Opens AI Center in Berlin and Supports AI Projects by Fabian Theis

Helmholtz Munich Secures Funding to Investigate Early-Stage Type 1 Diabetes in Adults

Arcangela Iuso Receives the Eva Luise Köhler Research Award

Press Contact